CA Stock MarketDetailed Quotes

Knight Therapeutics Inc (GUD)

Watchlist
  • 7.550
  • 0.0000.00%
15min DelayTrading May 5 16:00 ET
740.32MMarket Cap-151.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Knight Therapeutics Inc (GUD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
21.22%450.09M
37.42%133.11M
31.74%121.55M
12.33%107.36M
1.70%88.08M
13.13%371.3M
30.55%96.86M
13.21%92.26M
6.30%95.57M
4.85%86.6M
Operating revenue
21.22%450.09M
37.42%133.11M
31.74%121.55M
12.33%107.36M
1.70%88.08M
13.13%371.3M
30.55%96.86M
13.21%92.26M
6.30%95.57M
4.85%86.6M
Cost of revenue
26.90%249.86M
21.01%68.38M
39.14%65.74M
29.63%62.53M
18.49%53.21M
12.16%196.9M
41.34%56.51M
14.35%47.25M
-7.97%48.24M
7.34%44.91M
Gross profit
14.81%200.23M
60.40%64.72M
23.98%55.81M
-5.29%44.83M
-16.39%34.87M
14.25%174.41M
17.94%40.35M
12.03%45.02M
26.26%47.34M
2.30%41.7M
Operating expense
21.30%202.58M
35.10%58.51M
31.93%55.16M
13.20%48.5M
3.49%40.4M
14.17%167.01M
26.28%43.31M
6.53%41.81M
13.94%42.84M
11.13%39.04M
Selling and administrative expenses
24.92%124.11M
40.04%35.45M
21.75%31.02M
24.15%31.49M
12.75%26.14M
18.71%99.35M
33.78%25.32M
10.77%25.48M
15.32%25.36M
17.28%23.19M
-Selling and marketing expense
26.12%67.93M
40.10%20.42M
33.92%17.91M
18.17%15.67M
10.08%13.92M
16.38%53.86M
34.76%14.58M
12.14%13.37M
3.03%13.26M
18.60%12.65M
-General and administrative expense
23.51%56.18M
39.96%15.03M
8.31%13.12M
30.71%15.81M
15.95%12.22M
21.58%45.49M
32.46%10.74M
9.30%12.11M
32.68%12.1M
15.73%10.54M
Research and development costs
24.37%28.98M
25.23%9.22M
68.72%8.69M
8.18%6.28M
-3.90%4.79M
32.79%23.3M
72.97%7.37M
8.07%5.15M
33.90%5.81M
18.94%4.98M
Depreciation amortization depletion
11.57%49.49M
30.16%13.84M
38.17%15.45M
-8.08%10.73M
-12.86%9.47M
-1.52%44.36M
-4.36%10.63M
-2.62%11.18M
3.55%11.67M
-2.68%10.87M
-Depreciation and amortization
11.57%49.49M
30.16%13.84M
38.17%15.45M
-8.08%10.73M
-12.86%9.47M
-1.52%44.36M
-4.36%10.63M
-2.62%11.18M
3.55%11.67M
-2.68%10.87M
Operating profit
-131.77%-2.35M
309.80%6.21M
-79.83%646K
-181.64%-3.67M
-308.16%-5.54M
16.12%7.4M
-3,466.27%-2.96M
244.41%3.2M
4,185.45%4.49M
-52.78%2.66M
Net non-operating interest income (expenses)
-455.18%-4.22M
-1,358.14%-2.71M
-307.40%-1.26M
-216.00%-348K
53.13%98K
1,264.37%1.19M
121.31%215K
34.51%608K
261.45%300K
-88.59%64K
Non-operating interest income
-40.38%6.21M
-54.21%1.22M
-56.12%1.11M
-21.59%2.03M
-29.80%1.85M
-17.22%10.41M
-13.60%2.66M
-17.41%2.52M
-16.29%2.58M
-21.21%2.64M
Non-operating interest expense
13.00%10.42M
60.36%3.92M
23.66%2.37M
3.94%2.37M
-31.86%1.76M
-26.15%9.22M
-40.17%2.45M
-26.43%1.92M
-23.97%2.28M
-7.67%2.58M
Other net income (expenses)
97.92%-136K
-27.32%7.72M
59.35%-1.3M
-184.07%-11.59M
151.07%5.04M
77.04%-6.53M
142.38%10.62M
-142.62%-3.2M
-1,807.53%-4.08M
11.42%-9.87M
Gain on sale of security
96.90%-485K
-33.68%6.67M
71.53%-1.47M
-65.88%-10.3M
132.14%4.61M
38.45%-15.63M
159.56%10.06M
-221.22%-5.15M
-534.01%-6.21M
-21.73%-14.33M
Special income (charges)
-71.59%2.62M
-57.60%720K
-62.20%434K
-57.15%893K
-86.64%574K
254.88%9.23M
118.96%1.7M
-15.84%1.15M
129.52%2.08M
490.11%4.3M
-Less:Impairment of capital assets
----
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
71.59%-2.62M
57.60%-720K
62.20%-434K
57.15%-893K
86.64%-574K
-179.32%-9.23M
-460.40%-1.7M
15.84%-1.15M
-129.52%-2.08M
-490.11%-4.3M
Other non-operating income (expenses)
-1,661.24%-2.27M
128.99%329K
-134.09%-271K
-5,314.29%-2.19M
-182.84%-140K
-104.44%-129K
-245.14%-1.14M
-58.31%795K
-86.45%42K
279.79%169K
Income before tax
-426.61%-6.7M
42.53%11.22M
-415.30%-1.92M
-2,289.34%-15.61M
94.41%-399K
109.33%2.05M
130.11%7.88M
-93.17%608K
236.32%713K
-44.44%-7.14M
Income tax
41.75%-1.33M
182.87%2.37M
258.32%1.87M
-212.54%-2.99M
0.54%-2.58M
55.75%-2.28M
-56.63%-2.86M
175.80%523K
263.08%2.66M
-157.48%-2.6M
Earnings from equity interest net of tax
Net income
-224.05%-5.37M
-17.52%8.85M
-4,560.00%-3.79M
-549.95%-12.62M
148.06%2.19M
125.73%4.33M
144.13%10.74M
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
Net income continuous operations
-224.05%-5.37M
-17.52%8.85M
-4,560.00%-3.79M
-549.95%-12.62M
148.06%2.19M
125.73%4.33M
144.13%10.74M
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
Noncontrolling interests
Net income attributable to the company
-224.05%-5.37M
-17.52%8.85M
-4,560.00%-3.79M
-549.95%-12.62M
148.06%2.19M
125.73%4.33M
144.13%10.74M
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-224.05%-5.37M
-17.52%8.85M
-4,560.00%-3.79M
-549.95%-12.62M
148.06%2.19M
125.73%4.33M
144.13%10.74M
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
Diluted earnings per share
-225.00%-0.05
-10.00%0.09
-0.04
-550.00%-0.13
150.00%0.02
125.00%0.04
143.48%0.1
0
-200.00%-0.02
0.00%-0.04
Basic earnings per share
-225.00%-0.05
-10.00%0.09
-0.04
-550.00%-0.13
150.00%0.02
125.00%0.04
143.48%0.1
0
-200.00%-0.02
0.00%-0.04
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 21.22%450.09M37.42%133.11M31.74%121.55M12.33%107.36M1.70%88.08M13.13%371.3M30.55%96.86M13.21%92.26M6.30%95.57M4.85%86.6M
Operating revenue 21.22%450.09M37.42%133.11M31.74%121.55M12.33%107.36M1.70%88.08M13.13%371.3M30.55%96.86M13.21%92.26M6.30%95.57M4.85%86.6M
Cost of revenue 26.90%249.86M21.01%68.38M39.14%65.74M29.63%62.53M18.49%53.21M12.16%196.9M41.34%56.51M14.35%47.25M-7.97%48.24M7.34%44.91M
Gross profit 14.81%200.23M60.40%64.72M23.98%55.81M-5.29%44.83M-16.39%34.87M14.25%174.41M17.94%40.35M12.03%45.02M26.26%47.34M2.30%41.7M
Operating expense 21.30%202.58M35.10%58.51M31.93%55.16M13.20%48.5M3.49%40.4M14.17%167.01M26.28%43.31M6.53%41.81M13.94%42.84M11.13%39.04M
Selling and administrative expenses 24.92%124.11M40.04%35.45M21.75%31.02M24.15%31.49M12.75%26.14M18.71%99.35M33.78%25.32M10.77%25.48M15.32%25.36M17.28%23.19M
-Selling and marketing expense 26.12%67.93M40.10%20.42M33.92%17.91M18.17%15.67M10.08%13.92M16.38%53.86M34.76%14.58M12.14%13.37M3.03%13.26M18.60%12.65M
-General and administrative expense 23.51%56.18M39.96%15.03M8.31%13.12M30.71%15.81M15.95%12.22M21.58%45.49M32.46%10.74M9.30%12.11M32.68%12.1M15.73%10.54M
Research and development costs 24.37%28.98M25.23%9.22M68.72%8.69M8.18%6.28M-3.90%4.79M32.79%23.3M72.97%7.37M8.07%5.15M33.90%5.81M18.94%4.98M
Depreciation amortization depletion 11.57%49.49M30.16%13.84M38.17%15.45M-8.08%10.73M-12.86%9.47M-1.52%44.36M-4.36%10.63M-2.62%11.18M3.55%11.67M-2.68%10.87M
-Depreciation and amortization 11.57%49.49M30.16%13.84M38.17%15.45M-8.08%10.73M-12.86%9.47M-1.52%44.36M-4.36%10.63M-2.62%11.18M3.55%11.67M-2.68%10.87M
Operating profit -131.77%-2.35M309.80%6.21M-79.83%646K-181.64%-3.67M-308.16%-5.54M16.12%7.4M-3,466.27%-2.96M244.41%3.2M4,185.45%4.49M-52.78%2.66M
Net non-operating interest income (expenses) -455.18%-4.22M-1,358.14%-2.71M-307.40%-1.26M-216.00%-348K53.13%98K1,264.37%1.19M121.31%215K34.51%608K261.45%300K-88.59%64K
Non-operating interest income -40.38%6.21M-54.21%1.22M-56.12%1.11M-21.59%2.03M-29.80%1.85M-17.22%10.41M-13.60%2.66M-17.41%2.52M-16.29%2.58M-21.21%2.64M
Non-operating interest expense 13.00%10.42M60.36%3.92M23.66%2.37M3.94%2.37M-31.86%1.76M-26.15%9.22M-40.17%2.45M-26.43%1.92M-23.97%2.28M-7.67%2.58M
Other net income (expenses) 97.92%-136K-27.32%7.72M59.35%-1.3M-184.07%-11.59M151.07%5.04M77.04%-6.53M142.38%10.62M-142.62%-3.2M-1,807.53%-4.08M11.42%-9.87M
Gain on sale of security 96.90%-485K-33.68%6.67M71.53%-1.47M-65.88%-10.3M132.14%4.61M38.45%-15.63M159.56%10.06M-221.22%-5.15M-534.01%-6.21M-21.73%-14.33M
Special income (charges) -71.59%2.62M-57.60%720K-62.20%434K-57.15%893K-86.64%574K254.88%9.23M118.96%1.7M-15.84%1.15M129.52%2.08M490.11%4.3M
-Less:Impairment of capital assets ----------------------0----------------
-Less:Other special charges 71.59%-2.62M57.60%-720K62.20%-434K57.15%-893K86.64%-574K-179.32%-9.23M-460.40%-1.7M15.84%-1.15M-129.52%-2.08M-490.11%-4.3M
Other non-operating income (expenses) -1,661.24%-2.27M128.99%329K-134.09%-271K-5,314.29%-2.19M-182.84%-140K-104.44%-129K-245.14%-1.14M-58.31%795K-86.45%42K279.79%169K
Income before tax -426.61%-6.7M42.53%11.22M-415.30%-1.92M-2,289.34%-15.61M94.41%-399K109.33%2.05M130.11%7.88M-93.17%608K236.32%713K-44.44%-7.14M
Income tax 41.75%-1.33M182.87%2.37M258.32%1.87M-212.54%-2.99M0.54%-2.58M55.75%-2.28M-56.63%-2.86M175.80%523K263.08%2.66M-157.48%-2.6M
Earnings from equity interest net of tax
Net income -224.05%-5.37M-17.52%8.85M-4,560.00%-3.79M-549.95%-12.62M148.06%2.19M125.73%4.33M144.13%10.74M-99.11%85K-205.54%-1.94M-15.47%-4.55M
Net income continuous operations -224.05%-5.37M-17.52%8.85M-4,560.00%-3.79M-549.95%-12.62M148.06%2.19M125.73%4.33M144.13%10.74M-99.11%85K-205.54%-1.94M-15.47%-4.55M
Noncontrolling interests
Net income attributable to the company -224.05%-5.37M-17.52%8.85M-4,560.00%-3.79M-549.95%-12.62M148.06%2.19M125.73%4.33M144.13%10.74M-99.11%85K-205.54%-1.94M-15.47%-4.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -224.05%-5.37M-17.52%8.85M-4,560.00%-3.79M-549.95%-12.62M148.06%2.19M125.73%4.33M144.13%10.74M-99.11%85K-205.54%-1.94M-15.47%-4.55M
Diluted earnings per share -225.00%-0.05-10.00%0.09-0.04-550.00%-0.13150.00%0.02125.00%0.04143.48%0.10-200.00%-0.020.00%-0.04
Basic earnings per share -225.00%-0.05-10.00%0.09-0.04-550.00%-0.13150.00%0.02125.00%0.04143.48%0.10-200.00%-0.020.00%-0.04
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -